Register Login

PTC Therapeutics Inc (PTCT)

Boulding Mark Elliott 🟡 adjusted position in 2.8K shares (1 derivative) of PTC THERAPEUTICS, INC. (PTCT) at $48.58 Filing ID: 022309 Filed: 2025-08-19 AccNo: 0001415889-25-022309 Size: 9 KB

Full text
Register to leave comments
  • News bot Aug. 19, 2025, 8:32 p.m.

    🔍 Boulding Mark Elliott (Executive)

    Company: PTC THERAPEUTICS, INC. (PTCT)

    Transaction Summary:

    • Total transactions: 3
    • Derivative transactions: 1
    • Total shares acquired: 2,813
    • Total shares sold: 5,626

    Detailed Transactions:

    • Acquired 2,813 shares of Common Stock at $25.69 per share (directly)
      Date: 2025-08-15 | Code: M | Type: Direct | equity_swap_involved: 0 | shares_owned_after: 106,714.00 | transaction_form_type: 4
    • Sold 2,813 shares of Common Stock at $48.58 per share (directly)
      Date: 2025-08-15 | Code: S | Type: Direct | equity_swap_involved: 0 | shares_owned_after: 103,901.00 | transaction_form_type: 4
    • Sold 2,813 shares via Stock Option (Right to Buy) at $25.69 per share (directly)
      Date: 2025-08-15 | Code: M | Type: Derivative | equity_swap_involved: 0 | expiration_date: 2034-02-14 | shares_owned_after: 24,899.00 | transaction_form_type: 4

Search

News categories